Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A personalised online parenting intervention for adolescents at high risk of affective disorders: Results from the UK PIPA randomised controlled trial.

Journal of affective disorders·2026
Same author

A coach-supported, digital parenting programme for parents of adolescents at risk of suicide: pilot trial of acceptability, feasibility, validity and short-term effects.

BJPsych open·2026
Same author

Identifying Clinical Characteristics of Young People with Treatment-Resistant Schizophrenia Undergoing Community Initiation of Clozapine.

Schizophrenia bulletin·2026
Same author

Structured Illumination Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Initial physical health assessment for psychosis in Australia and New Zealand: 2026 recommendations.

The Australian and New Zealand journal of psychiatry·2026
Same author

Impact of Early Intervention Services on Substance Use Outcomes Among Young People at Risk for Psychosis.

Psychiatric services (Washington, D.C.)·2026

Related Experiment Video

Updated: Dec 8, 2025

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

29.0K

Putaminal diffusion tensor imaging measures predict disease severity across human prion diseases.

Harpreet Hyare1, Enrico De Vita2, Marie-Claire Porter1

  • 1MRC Prion Unit at UCL, Institute of Prion Diseases, London SE1 7EH, UK.

Brain Communications
|September 21, 2020
PubMed
Summary

Cerebral water diffusivity, specifically in the putamen, shows promise as a biomarker for prion disease severity. This imaging measure could aid in future therapeutic trials for these rare neurodegenerative conditions.

Keywords:
CJDMRIprion

More Related Videos

Diffusion Tensor Magnetic Resonance Imaging in Chronic Spinal Cord Compression
07:00

Diffusion Tensor Magnetic Resonance Imaging in Chronic Spinal Cord Compression

Published on: May 7, 2019

9.2K
Advanced Diffusion Imaging in The Hippocampus of Rats with Mild Traumatic Brain Injury
10:33

Advanced Diffusion Imaging in The Hippocampus of Rats with Mild Traumatic Brain Injury

Published on: August 14, 2019

8.8K

Related Experiment Videos

Last Updated: Dec 8, 2025

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

29.0K
Diffusion Tensor Magnetic Resonance Imaging in Chronic Spinal Cord Compression
07:00

Diffusion Tensor Magnetic Resonance Imaging in Chronic Spinal Cord Compression

Published on: May 7, 2019

9.2K
Advanced Diffusion Imaging in The Hippocampus of Rats with Mild Traumatic Brain Injury
10:33

Advanced Diffusion Imaging in The Hippocampus of Rats with Mild Traumatic Brain Injury

Published on: August 14, 2019

8.8K

Area of Science:

  • Neuroscience
  • Radiology
  • Biomarker Discovery

Background:

  • Prion diseases are rare neurodegenerative disorders requiring large, long trials for drug development.
  • Biomarkers are crucial for assessing disease progression and treatment efficacy in rare diseases.
  • Diffusion-weighted MRI shows characteristic abnormalities in prion diseases.

Purpose of the Study:

  • To investigate cerebral water diffusivity as a quantitative imaging biomarker for prion disease severity.
  • To determine if diffusivity changes in the basal ganglia correlate with disease progression.

Main Methods:

  • Diffusion tensor imaging (DTI) and voxel-based analysis were performed on 37 prion disease patients and 34 controls.
  • Neurological function was assessed using the Medical Research Council Scale.
  • Region of interest analysis focused on the putamen for diffusivity measurements.

Main Results:

  • Decreased putamen diffusivity (mean, radial, axial) correlated significantly with lower Medical Research Council Scale scores.
  • Patients showed a significant decline in putamen diffusivity over time compared to controls.
  • The rate of decrease in putamen radial diffusivity strongly predicted the rate of decline in neurological function.

Conclusions:

  • Putamen radial diffusivity is a potential quantitative imaging biomarker for prion disease severity.
  • This biomarker could serve as a secondary outcome measure in future therapeutic trials.
  • Sample size calculations suggest feasibility for intervention studies using this biomarker.